Drug Approval | June 25, 2025
Lupin receives USFDA approval for Prucalopride Tablets
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation in adults
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation in adults
The CR Bio unit represents a non-core legacy asset with limited strategic alignment to our core CDMO operations
The transaction is expected to close in Q2 FY 2026
The proceeds from the QIP will be utiized for purchase of outstanding optionally convertible debentures
Conceptulised by Lowe Lintas, the new campaign creatively brings the "fast action" benefit of Cipladine to life through a series of films
Dilip Shanghvi to continue as the Executive Chairman of the Board
Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,
Oxcarbazepine ER Tablets (RLD Oxtellar XR) had estimated annual sales of US$ 206 million in the US (IQVIA MAT April 2025)
This is specifically for the evaluation of medicines that, if approved, would provide a significant improvement in the safety or effectiveness of the treatment, prevention, or diagnosis of a serious condition
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
Subscribe To Our Newsletter & Stay Updated
